CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with ...

"Publication of the new AMA CPT code represents a significant milestone for Sensydia, and will help foster the adoption of our nninvasive, in-clinic hemodynamic assessment tool by establishing a ...

Cleerly, a leader in AI-based cardiovascular imaging, today announced that Aetna will begin covering Cleerly ® LABS plaque ...

This coverage milestone follows the American Medical Association’s recent implementation of the new Category I Current Procedural Terminology (CPT ®) payment code 75577 for Heartflow Plaque Analysis, ...

Interventional cardiologists say some cases that coders flag and submit to the NCDR aren’t in fact problematic.

Q2 2026 Earnings Call Transcript January 6, 2026 AngioDynamics, Inc. misses on earnings expectations. Reported EPS is ...

Q2 FY2026 earnings call recap: revenue up 8.8%, Auryon & NanoKnife growth, raised guidance, margin outlook and risks—read now.

Lipoprotein(a), a fatty particle, can clog arteries just as surely as cholesterol but often goes undetected, striking ...

("Canacol" or the "Company") refers to its prior announcement regarding the Company's agreement for debtor-in-possession financing and related documentation (the "DIP Financing"). In that announcement ...

For decades, chronic disease management in Medicare has been hampered by a fee-for-service payment system that rewards volume and activity rather than true clinical improvement. This model created ...

IVDs are essential for disease detection, personalized treatment, and public health, driving growth in the global diagnostics ...

Background The National Heart Failure Audit gathers data on patients coded at discharge (or death) as having heart failure as ...